A team of Stanford University researchers has come up with a “cancer vaccine” that has proven effective in curing mice of different forms of the disease. Due to the treatment’s initial success, it might not be long before it gets tested on human patients.
According to the National Cancer Institute website, cancer vaccines are classified into two categories — preventive vaccines, which are designed to protect healthy individuals from the disease, and treatment vaccines, which strengthen the immune system in an attempt to treat existing forms of cancer. Only three individual types are officially available to U.S. patients, including preventive vaccines for human papillomavirus and hepatitis B, and a treatment vaccine for metastatic prostate cancer. The newly developed vaccine falls into the second category, and unlike other existing treatment vaccines, it does not require any customization of immune cells.
0 comments :
Post a Comment